Harbor Capital Advisors Inc. increased its holdings in Maximus, Inc. (NYSE:MMS – Free Report) by 91.9% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 33,019 shares of the health services provider’s stock after purchasing an additional 15,810 shares during the period. Harbor Capital Advisors Inc. owned approximately 0.05% of Maximus worth $3,076,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of MMS. Assenagon Asset Management S.A. increased its holdings in shares of Maximus by 277.0% during the third quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider’s stock worth $81,878,000 after buying an additional 645,760 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of Maximus by 942.9% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock valued at $27,707,000 after purchasing an additional 292,300 shares in the last quarter. Millennium Management LLC increased its holdings in shares of Maximus by 150.4% in the second quarter. Millennium Management LLC now owns 406,075 shares of the health services provider’s stock valued at $34,801,000 after purchasing an additional 243,890 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Maximus by 2.4% in the first quarter. Vanguard Group Inc. now owns 6,208,839 shares of the health services provider’s stock valued at $520,922,000 after purchasing an additional 145,983 shares in the last quarter. Finally, Algert Global LLC acquired a new stake in shares of Maximus in the second quarter valued at approximately $12,424,000. Institutional investors and hedge funds own 97.21% of the company’s stock.
Insider Buying and Selling at Maximus
In other Maximus news, insider Michelle F. Link sold 1,363 shares of the firm’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total value of $126,159.28. Following the transaction, the insider now directly owns 6,567 shares of the company’s stock, valued at approximately $607,841.52. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.40% of the company’s stock.
Maximus Stock Performance
Maximus (NYSE:MMS – Get Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The health services provider reported $1.74 earnings per share for the quarter, beating analysts’ consensus estimates of $1.47 by $0.27. The business had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.59% and a return on equity of 20.91%. Maximus’s revenue for the quarter was up 10.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.78 earnings per share. Sell-side analysts predict that Maximus, Inc. will post 6.12 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Saturday, November 30th. Shareholders of record on Friday, November 15th will be paid a $0.30 dividend. The ex-dividend date is Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.37%. Maximus’s payout ratio is presently 25.16%.
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories
- Five stocks we like better than Maximus
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Intel: Is Now the Time to Be Brave?Â
- The 3 Best Retail Stocks to Shop for in August
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How to Capture the Benefits of Dividend Increases
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.